Zynerba Pharmaceuticals, Inc. (ZYNE): Price and Financial Metrics
Zynerba Pharmaceuticals, Inc. (ZYNE)
Today's Latest Price: $4.49 USD
0.02 (0.45%)
Updated Dec 2 4:00pm
Add ZYNE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ZYNE Stock Summary
- Zynerba Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.07% of US listed stocks.
- With a price/sales ratio of 1,661.62, Zynerba Pharmaceuticals Inc has a higher such ratio than 99.79% of stocks in our set.
- The volatility of Zynerba Pharmaceuticals Inc's share price is greater than that of 93.47% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Zynerba Pharmaceuticals Inc, a group of peers worth examining would be BPMX, RVNC, ADVM, PSTI, and PRTA.
- Visit ZYNE's SEC page to see the company's official filings. To visit the company's web site, go to www.zynerba.com.
ZYNE Stock Price Chart Interactive Chart >
ZYNE Price/Volume Stats
| Current price | $4.49 | 52-week high | $7.45 |
| Prev. close | $4.47 | 52-week low | $2.55 |
| Day low | $4.20 | Volume | 444,062 |
| Day high | $4.55 | Avg. volume | 912,808 |
| 50-day MA | $3.73 | Dividend yield | N/A |
| 200-day MA | $4.06 | Market Cap | 132.18M |
Zynerba Pharmaceuticals, Inc. (ZYNE) Company Bio
Zynerba Pharmaceuticals is a specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company was founded in 2007 and is based in Devon, Pennsylvania.
Loading social stream, please wait...